Ensifentrine (Ohtuvayre) acts as bronchodilator and non-steroidal anti-inflammatory agent. It is formulated as suspension for inhalational route of administration. Ohtuvayre is indicated for the ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

INR:5815. sikkim state lottery live draw New drug for cystic fibrosis! Kalydeco approved by the EU for use in infants aged 4-6 months The ranking o ...

crazy time result Science: Revealing the structure of hinge-like protein provides new ideas for treating cystic fibrosis Why did China's first province-wide prescription circulation fall into the ...

This year marked the 22 nd anniversary of Carols by Candlelight, an annual event held in memory of Alice Martineau, a ...

INR:0955. crypto games casino Beijing Nanjiao Cancer Hospital suspended outpatient services due to suspicious nucleic acid test results on garbage truck Big n ...

According to Vertex Pharmaceuticals, approximately 300 additional people with CF are now eligible to receive treatment.

Krystal Biotech's VYJUVEK, a groundbreaking gene therapy for DEB, achieved $83.8M in Q3 2024 sales. Read why I rate KRYS ...

Researchers at National Jewish Health and colleagues have completed the first study comparing lung macrophages in multiple ...

In STAT's "jealousy list" for 2024, STAT staffers explain what makes a selection of stories they read in other publications ...

A $42,000 grant from NASA and INBRE will further CF research, through a collaborative effort spanning to India and the United Kingdom.

The Food and Drug Administration (FDA) has approved Alyftrek ™ (vanzacaftor/tezacaftor/deutivacaftor) for the treatment of cystic fibrosis (CF) in patients aged 6 years and older who have at least one ...